Clinical Trial Update: Avapritinib Maintenance for AML With KIT Mutations [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating maintenance avapritinib in adults with acute myeloid leukemia harboring KIT mutations; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Avapritinib (Ayvakit) (avapritinib)

Snippet

Sponsor: Ruijin Hospital | Conditions: AML, Adult | Phase 2 | Status: NOT_YET_RECRUITING